Lifecore Biomedical, Inc. (LFCR) NASDAQ
3.84
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.84
+0(+0.00%)
Currency In USD
| Market Cap | 233.98M |
| Enterprise Value | 356.54M |
| P/E Ratio | -4.25 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 0.98 |
| Price/Book Ratio | 4.22 |
| Enterprise/Revenue | 1.84 |
| Enterprise/EBITDA | -126.87 |
| Fiscal Year | May 25, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.23 |
| Operating Margin | -0.03 |
| Return On Assets | -0.15 |
| Return On Equity | -1.82 |
| Revenue | 128.87M |
| Revenue/Share | 3.93 |
| Gross Profit | 40.3M |
| EBITDA | -8.81M |
| Net Income | -38.72M |
| Diluted EPS | -1.27 |
| Total Cash | 17.47M |
| Total Cash/Share | 0.47 |
| Total Debt | 143.91M |
| Total Debt/Equity | 4.23 |
| Current Ratio | 3.49 |
| Book Value Per Share | 0.91 |
| 52-Week Change | -43.61 |
| 52-Week High | 8.98 |
| 52-Week Low | 3.63 |
| Moving Average 50 Days | 6.53 |
| Moving Average 200 Days | 7.28 |
| Average Volume | 264,454 |
| Shares Outstanding | 37.48M |
| % Held by Institutions | 66.28 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |